Erasca, Inc. (ERAS)
18.42
+0.82
(+4.66%)
USD |
NASDAQ |
Aug 25, 10:30
Erasca Total Return Level : 17.60 for Aug. 24, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| August 24, 2026 | 17.60 |
| August 21, 2026 | 17.63 |
| August 20, 2026 | 17.08 |
| August 19, 2026 | 18.07 |
| August 18, 2026 | 18.10 |
| August 17, 2026 | 18.28 |
| August 14, 2026 | 18.38 |
| August 13, 2026 | 17.86 |
| August 12, 2026 | 18.58 |
| August 11, 2026 | 18.31 |
| August 10, 2026 | 18.12 |
| August 07, 2026 | 18.41 |
| August 06, 2026 | 18.27 |
| August 05, 2026 | 18.62 |
| August 04, 2026 | 18.38 |
| August 03, 2026 | 17.84 |
| July 31, 2026 | 18.15 |
| July 30, 2026 | 18.68 |
| July 29, 2026 | 17.72 |
| July 28, 2026 | 18.16 |
| July 27, 2026 | 18.87 |
| July 24, 2026 | 19.11 |
| July 23, 2026 | 19.34 |
| July 22, 2026 | 19.51 |
| July 21, 2026 | 19.38 |
| Date | Value |
|---|---|
| July 20, 2026 | 18.82 |
| July 17, 2026 | 19.17 |
| July 16, 2026 | 19.02 |
| July 15, 2026 | 21.26 |
| July 14, 2026 | 19.50 |
| July 13, 2026 | 17.90 |
| July 10, 2026 | 18.53 |
| July 09, 2026 | 19.18 |
| July 08, 2026 | 18.87 |
| July 07, 2026 | 18.36 |
| July 06, 2026 | 18.85 |
| July 02, 2026 | 18.47 |
| July 01, 2026 | 17.92 |
| June 30, 2026 | 18.32 |
| June 29, 2026 | 18.29 |
| June 26, 2026 | 16.01 |
| June 25, 2026 | 14.95 |
| June 24, 2026 | 15.05 |
| June 23, 2026 | 15.07 |
| June 22, 2026 | 15.08 |
| June 18, 2026 | 13.67 |
| June 17, 2026 | 13.98 |
| June 16, 2026 | 13.38 |
| June 15, 2026 | 14.43 |
| June 12, 2026 | 14.05 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Revolution Medicines, Inc. | 211.58 |
| Tango Therapeutics, Inc. | 24.51 |
| Cogent Biosciences, Inc. | 36.23 |
| Apogee Therapeutics, Inc. | 134.79 |
| Arrowhead Pharmaceuticals, Inc. | 86.73 |